期刊文献+

糖链抗原125在心力衰竭中的作用

Significance of carbohydrate antigen 125 detection in the patients with heart failure
下载PDF
导出
摘要 目的探讨心力衰竭患者糖链抗原125(CA125)血浓度的变化情况及其临床意义。方法分别在25例正常人和65例治疗前、后出现心力衰竭的患者(按NYHA心功能分级分为Ⅱ~Ⅳ级)中,测定CA125和B型钠尿肽(BNP)浓度。结果治疗前心力衰竭患者血CA125浓度为(74.92±24.92)nmol/L,明显高于正常对照组(20.77±13.64)nmol/L,P<0.01;BNP浓度([399.48±286.60)nmol/L]亦明显高于正常对照组([64.45±42.32)nmol/L],P<0.01。治疗后心力衰竭患者血CA125浓度为(45.76±16.47)nmol/L,明显低于治疗前水平,P<0.01;治疗后心力衰竭患者BNP浓度([184.98±99.33)nmol/L]亦明显低于治疗前水平,P<0.01,且CA125浓度与心功能分级间存在正相关性(r=0.5629,P<0.01)。CA125浓度与BNP水平也存在正相关性(r=0.5137,P<0.01)。结论心力衰竭患者血清肿瘤标志物CA125含量可明显升高,经治疗症状好转后又能迅速下降。而且,CA125浓度与BNP浓度、患者病情严重程度有一定相关性,其变化程度对评价心功能的程度和转归可能有一定的参考价值;另外,CA125浓度亦可见于非恶性肿瘤性疾病。 【Objective】To investigate the changes and significance of tumor marker carbohydrate antigen 125(CA125) in the patients with heart failure.【Methods】The serum concentration of CA125 and plasma B-type natriuretic peptide(BNP) were measured in 25 normal people as control group and in 65 patients with heart failure(HF)(according to the criterion of NYHA classes,HF patients were Ⅱ class~IV class heart function).【Results】The blood concentration of CA125 and the BNP in heart failure groups were higher than that in control group respectively(74.92±24.92)nmol/L,(20.77±13.64)nmol/L(P 0.01);and(399.48±286.60)nmol/L,(64.45±42.32)nmol/L(P 0.01).After the treatment,the blood concentration of CA125 and the BNP in heart failure groups were lower than that before the treatmentl group respectively(45.76±16.47)nmol/L,(P 0.01);and(184.98±99.33)nmol/L,(P 0.01).There were positive relationship between the blood concentration of CA125 and the level of heart function in heart failure groups(r =0.5629,P 0.01).There were positive relationship between the blood concentration of CA125 and BNP(r =0.5137,P 0.01).【Conclusion】The serum concentration of CA125 may increase in the HF patients,but it may decrease after the effective treatment.There are some positive relationship between the blood concentration of CA125 and the blood concentration of BNP,the severity of heart failure.The changes of the serum CA125 is of valuable for evaluating the heart function and the prognosis of heart failure patients.The serum CA125 concentration could also been found higher levels in other diseases besides malignant.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第16期2499-2502,共4页 China Journal of Modern Medicine
关键词 心力衰竭 肿瘤标志物 糖链抗原125 B型钠尿肽 heart failure tumor marker carbohydrate antigen 125 B-type natriuretic peptide
  • 相关文献

参考文献21

  • 1DUMAN D, PALIT F, SIMSEK E, et al. Serum carbohydrate antigen 125 levels in advanced heart failure relation to B-type natriuretic peptide and left atrial volume [J]. Eur J Heart Fail, 2008, 10(6): 556--559.
  • 2MANSOUR IN, NAPAN S, TAREK AM, et al. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute deeompensated heart failure[J]. Congest Heart Fail, 2010, 16(1): 15-20.
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3684
  • 4ARNOLD JM, LIU P, DEMERS C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management [J]. Can J Cardiol 2006, 22(1): 23-45.
  • 5DANIELS LB, CLOPTON P, JIANG K, et al. Prognosis of stage A or B heart failure patients with elevated B-type natrittretic peptide levels[J]. J Card Fail. 2010, 16(2): 93-98:.
  • 6BAST R J, FEENEY M, LAZARUS H. Reactivity of a monodonal antibody with human ovarian carcinoma [J]. J Clin Invest, 1981, 68(5): 1331-1337.
  • 7NAGELE H, BAHOL M, KLAPDOR R, et al. CA125 and its relation to cardiac function [J]. Am Heart J, 1999, 137(6): 1044-1049.
  • 8TZITZIKOS G, SARIDI M, FILIPPOPOULOU T, et al. Measure- ment of tumor markers in chronic hemodialysis patients [J]. Saudi J Kidney Dis Transpl, 2010, 21(1): 50-53.
  • 9LOCKHART CJ, MCVEIGH GE, HARBINSON MT, et al. Elerated CA 125 and aseites: not always malignancy [J]. Ir J Med Sci, 2008, 177(1): 63-66.
  • 10BULLEN AW, LOSOWSKY MS, CARTER S, et al. Diagnostic usefulness of plasma earcinoembryonic antigen levels in acute and chronic liver disease [J]. Gastroenterology, 1977, 73 (4 pt), 673-678.

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3683

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部